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iii.  Abstract 
 
Mouse; PGCs (Primordial Germ Cells); Mesendoderm; Smad1/5; CHIR99021 
 
The developmental pathway of Primordial Germ Cells (PGCs) is not only complex but it is 
also critical for the reproduction and continuity of species. Deepening our understanding of the 
mechanisms that underlie PGCs acquired identity along with maintenance of totipotency (until 
the event of fertilization) paradox would give us useful insight for further translational research. 
PGCs in mice are known to arise from the epiblast due to specific time/place signalling. 
Molecules that are already identified as being involved in PGC competence and specification 
include Fragilis, Blimp1, Prdm14 and Stella. Additionally, there is an increase in alkaline 
phosphatase enzyme activity. BMP4 and its downstream targets Smad1 and Smad5 are some of 
the factors thought to initiate the PGC signalling pathway. 
 Several efforts to maintain these cells proliferating in vitro have been made. Current in 
vitro practices include culture in either serum and fibroblast-feeder layer or the 2i-medium (2i = 
2 inhibitors) that includes the inhibitor cytokines CHIR99021 (CHIR) and PD0325901 (PD) and 
Leukemia Inhibitory Factor (LIF) to maintain cell pluripotency.   
Hayashi et al1 has been able to induce PGC-like cells (PGCLCs). Using mouse embryonic 
stem cells (mESCs) cultured 2i it relies on a time-specific induction by first inducing Epiblast-like 
cells (EpiLCs) and only afterwards inducing PGCLCs. Molecules like Activin A, basic fibroblast 
growth factor (bFGF) were used for inducing EpiLCs while bone morphogenetic protein 4 
(BMP4) with BMP8b, Stem Cell Factor (SCF), LIF and Epidermal Growth Factor (EGF) was used 
for inducing PGCLCs. 
However, the cytokine CHIR99021, when used alone, has been shown to induce other 
cells types, for example mesendoderm. Since PGCs need inducing signals from the 
mesendoderm, it should be possible to generate PGCs from EpiLCs being induced to 
differentiate to mesendoderm.  
In this study, mesoderm and endoderm markers Brachyury-T and Sox17, respectively, 
were analyzed along with Oct4 and Nanog pluripotency markers, and Blimp1 and Stella, as PGC 
markers. Wildtype and Smad5 deficient mESC were analysed, followed by an attempt to 
generate of Smad5 KO Blimp1:rfp for detection in living cells of PGCLCs induction. 
Unfortunately, we were unable to generate Smad5 KO containing the reporter transgene. 
Therefore we analysed other genetic mutant mESC line, the double Smad1 Smad5 KO mESCs to 
determine the efficiency of PGCLC in a protocol for mesendoderm formation. 
From our results it remains unclear whether induction of mesendoderm in EpiLCs 
resulted in more efficient PGC induction. Nevertheless, the induction of Blimp1 is shown to be 
independent of BMP signalling activation by Smad1/5, since it was observed in the double 
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As Células Germinais Primordiais (CGPs) são responsáveis pela continuidade das espécies. A 
formação de CGPs é dependente de uma rede complexa de sinalização molecular coordenada 
no espaço e no tempo durante o desenvolvimento embrionário. A especificação destas células 
consiste em manter as células pluripotentes durante o desenvolvimento do animal, até que 
este atinja a maturidade e seja capaz de se reproduzir. A instrução destas células vai no sentido 
oposto da diferenciação tradicional no sentido em que, neste caso, as células estão a ser 
instruídas a permanecer pluripotentes. 
Em ratinho, as células do epiblasto junto da base da alantóide começam a expressar 
Fragilis e dessa forma a ganhar competência para formar CGPs. Aquelas que contam com 
maiores níveis da proteína Fragilis vão começar a expressar Blimp1, Prdm14 e Stella, 
sequencialmente. Também existe um aumento da activade da enzima fosfatase alcalina em 
CGPs quando se inicia a expressão de Stella.  
Pensa-se que a sinalização por BMP4, segregado pela ectoderme extra-embrionária,  e 
BMP2, da endoderme visceral, (e os seus alvos a jusante) seja a responsável pela indução da 
expressão diferencial de Fragilis no epiblasto. Os tecidos de onde são segregados estes BMPs 
ladeiam a área da base da alantóide, criando um nicho de factores favorável à especificação de 
CGPs. De seguida algumas destas células começam a expressar Blimp1 e Prdm14, mais tarde 
começando a expressar Stella, adquirindo a identidade de CGP. 
O desempenho de funções essenciais do BMP4 na diferenciação de CGPs foi 
demonstrado pelas deficiências dos portadores de mutações nos genes de Smad 1 e Smad5. 
Nos indivíduos sem Smad1 funcional, verifica-se a ausência de CGPs enquanto nos indivíduos 
com o Smad5 mutado ocorre uma diminuição do número total de CGPs juntamente com o 
aparecimento de CGPs ectópicas.  
Desde a descoberta de CGPs em mamíferos que foram sendo feitos esforços no sentido 
de tentar manter estas células em cultura no laboratório, tendo mais tarde o interesse passado 
para a sua geração in vitro a partir de Células Estaminais Embrionárias (CEEs). O conhecimento 
dos mecanismos que operam nestas células permitiria eventualmente, a partir de uma célula 
pluripotente (CEEs), originar todos os tipos de tecido.  Tal como acontece in vivo, em que as 
células adquirem a identidade de CGPs até ser dado um sinal em contrário, que neste caso seria 
a fertilização e consequentemente a formação do zigoto, a partir do qual estas células são 
capazes de dar origem a todos os tipos de células. Para além da vertente mais imediatamente 
aplicável na área da reprodução medicamente assistida (formação de gâmetas in vitro), estes 
conhecimentos contribuem para a investigação na área de diferenciação de outros tecidos in 
vitro a partir de CEEs. 
 
Actualmente, a maioria das culturas in vitro são feitas sem fibroblastos e sem soro. Estes 
factores contribuem com variáveis desconhecidas para o comportamento das células, fazendo 
com que as várias células estejam em estados de transcrição diferentes, originando uma cultura 




O meio N2B27 não contém soro, sendo conhecido como meio de base para 
diferenciação neuronal. Quando este contém CHIR99021 (CHIR), PD0325901 (PD) e LIF, o meio 
é chamado “2i” (2 inibidores), e é capaz de manter CEEs no seu estado pluripotente de uma 
forma mais homogénea.  
PD actua pelo bloqueio da sinalização FGF através da inibição de MEK. CHIR é uma 
molécula da via de sinalização Wnt/beta-catenina que actua através da inibição de GSK3, esta 
última sendo responsável pela degradação da beta-catenina. Com a estabilização da beta-
catenina pelo uso de CHIR, esta pode migrar para o núcleo e servir de factor de transcrição. Por 
si só, o CHIR suprime a diferenciação neuronal, induzindo outros tipo de diferenciação não-
neuronal. Ocorre também por resultado da adição de CHIR, o aumento de Nanog, diminuição 
de Nodal e aumento de BMP4 e os seus efectores a jusante Smad1 e 5.  
Recentemente, o grupo de Hayashi e colegas 1  utilizando CEEs cultivadas com 2i foi bem 
sucedido em gerar CGPs. O protocolo usado baseia-se no facto de in vivo ser possível distinguir 
duas etapas de diferenciação. Primeiro, ocorre a diferenciação em células do epiblasto e numa 
segunda fase, a combinação específica de vários factores, fará com que algumas dessas células 
se comprometam para CGPs. No protocolo a indução começa com a adição das moléculas 
Activina A e bFGF para, nesta primeira fase, gerar células tipo-epiblasto e apenas 
posteriormente é adicionado BMP4 juntamente com BMP8b, SCF, LIF e EGF para gerar células 
tipo-CGPs. 
No entanto, apenas com a adição de CHIR é possível diferenciar células em 
mesendoderme, e verifica-se nestas células um aumento de BMP4 e Smad1/5 que deveria 
auxiliar a geração de CGPs sem ser necessário factores indutores adicionais. 
Para testar se é possível obter CGPs com a ajuda de factores secretados por células que 
estão a diferenciar em células mesendodermais, foi utilizada a linha CEE E14. Adicionalmente, 
para investigar se o Smad1 e o Smad5 estão envolvidos na diferenciação de mesendoderme 
e/ou de CGPs, foram utilizadas linhas CEE mutantes. Tentámos obter uma linha transgénica 
Smad5 nula com o gene rfp como reporter e ademais foram também derivadas células duplas 
mutantes com sites loxP a flanquear o gene Smad1 e Smad5 (Smad1fl/fl Smad5fl/fl). Foram 
testadas a linha mãe (WT), contendo apenas os locais loxP, e 3 outras linhas, expostas à 
actividade da recombinase Cre, tendo o Smad1 e Smad5 não funcional (knocked out). 
O projecto scientífico apresentado aqui consiste na diferenciação destas CEEs em 3 
meios distintos durante 6 dias. Foram utilizados os meios: “N2B27” que direcciona as células 
para a linhagem neuronal; N2B27 com a adição de CHIR99021, “CHIR”,  com vista a induzir a 
mesendoderme e consequentemente produzir factores que levam EpiLCs a produzir CGPs, e 
por fim foi utilizado o meio “MEF” em que se espera diferenciação espontânea para múltiplas 
linhagens celulares devido à utilização de soro. 
Numa análise inicial foi utilizada a coloração para a enzima fosfatase alcalina (FA), uma 
das primeiras e principais técnicas de detecção de CGPs (e EECs), para análise das 
características morfológicas das diferentes densidades de sementeira em cultura monocamada. 
Em menor densidade as células adquirem uma aparência epitelial mantendo alguns nichos 
onde é possível ver coloração positiva para a enzima. Em densidade de sementeira superior, 
todas as células se apresentam negativas para a presença da enzima (demosntrando apenas 
coloração de fundo). Por existir maior número de células, isto poderá ser atribuido à inibição da 
diferenciação pelo contacto extensivo entre EECs. 
Após a escolha da densidade mais baixa de sementeira foi efectuada imunohistoquímica 
para os marcadores de mesendoderme Brachyury-T (mesoderme) e Sox17 (endoderme) para 
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verificar a formação de mesendoderme nas linhas controlo (E14 e linha WT) em contraste com 
as linhas floxed Smad1-/- Smad5-/-. É também analisado o factor de pluripotência Nanog (que 
passa a ser infrarregulado assim que as células estão competentes para diferenciação, voltando 
a ser expresso em CGPs), que poderá fornecer informação relativamente à pluripotência das 
células e competência para diferenciação. 
Os resultados relativos à produção de mesendoderme nas CEEs E14, mostram que a 
diferenciação para mesendoderme foi eficaz após os 6 dias de diferenciação. Verificou-se a 
presença dos marcadores de mesoderme (Brachyury-T) e endoderme (Sox17) especificamente 
na condição CHIR, enquanto o marcador de pluripotência/CGPs (Nanog) é produzido em todas 
as condições (N2B27 para ectoderme, N2B27+CHIR para mesendoderme e MEF para 
diferenciação espontânea). Especificamente na condição CHIR, parece formar um aglomerado 
apertado. Verifica-se também nas CEEs E14 que há um aumento de Stella, o que indica a 
diferenciação de CGPs. Para além  do aumento de Stella, o PCR quantitativo para os genes da 
rede de pluripotência (Oct4 e Nanog), e o outro gene especifico de CGPs (Blimp1), mostra 
algumas diferenças relevantes em que a expressão é mais elevada no protocolo “CHIR” após 6 
dias de diferenciação. 
No protocolo “CHIR” (para mesendoderme) aplicado às CEEs mutantes Smad1-/- Smad5-/- 
derivadas, verifica-se também a expressão de marcadores de mesoderme (Brachyury-T) e 
endoderme (Sox17) assim como Nanog (marcador de pluripotência/CGPs). O Nanog apresenta-
se em maior quantidade, num aglomerado apertado, na linha WT enquanto que nas linhas K.O. 
(excepto a linha 1.35) se apresenta relativamente em menor quantidade e mais disperso. 
Conclui-se que o tratamento com CHIR99021 também é capaz de induzir a expressão de 







The interest in ES (embryonic stem) cells as model for a wide range of studies, such as 
disease modelling, signalling pathway analysis, and in overall in vitro behaviour upon exposure 
to different conditions, is continuously growing. ESCs can be kept in the naïve state, which 
resembles the preimplantation epiblast, displaying unlimited self-renewal capacity and 
pluripotency. This state has both X chromosomes active (in the case of cells carrying two X 
chromosomes), which is an epigenetic signature for the naïve ground state of pluripotency. In 
vivo, the epiblast cells will become primed after implantation, one of the X chromosomes will 
inactivate and the cells become competent to differentiate into other cell types. In culture, 
these cells are called EpiSCs and like the ESCs still express pluripotency factors, e.g. Oct4, Sox2, 
and Nanog, although they are not able to contribute to chimeras. On the contrary, naïve ESCs 
contribute to chimera’s somatic portion as well as germ cell lineage.  
Germ cells are a special kind of cells that have to go through steps of differentiation and 
dedifferentiation2. Differentiation of these cells in vitro would represent a great step to 
understand their development and characteristics, which would contribute to the advance of 
assisted reproduction for infertile couples, for instance, although there are major differences 
between SCs from different species. 
In the mouse model it is known that BMP4 and its downstream targets play an 
important role in PGC differentiation3. So far there is one protocol that succeeded in 
differentiating PGCs in vitro that were able to mature in vivo after transplantation into 
functional gametes and generate viable progeny4,5. Although it did result in viable offspring, this 
protocol relies on a step-by-step differentiation with the addition of several signalling 
molecules during the first differentiation step to PGCs, but could consequently bias the study of 
processes that happen along their differentiation. In general, molecules do not have a single 
function, but are included in various cellular processes: CHIR modulated genes, for instance, 
have been reported to regulate more than 50 signalling pathways6. CHIR is a Wnt signalling 
pathway activator that has a wide array of pleiotropic results7. Which Wnt target genes get 
activated depend on the history of the cell where Wnt signalling is acting upon8. CHIR is a 
molecule widely used in vitro, alongside others, to maintain stem cell pluripotency through the 
stabilization of β-catenin9–11. When no other supplementary factors are added to the culture 
medium, CHIR is actually capable of inducing differentiation other than neural12. CHIR has been 
used to generate mesendodermal progenitors, in a monolayer, through sustained Wnt pathway 
activation. These cells showed the expression of meso/endodermal markers such as 
T-brachyury, Sox17, Gata2, among others13. BMP4 has been shown to be expressed at the same 
time in different parts of the early embryo, being involved in the formation of PGCs, the lens 
placode and the kidneys14. It would therefore be useful to have a simpler protocol for the study 








1. Embryonic Stem Cells in mouse 
 
In 1981, Evans et al.15 were able to derive a pluripotent cellular line (capable of 
differentiating into 3 embryonic germ layers in vitro and in vivo) directly from cultured 
preimplantation mouse blastocysts and maintaining the cells self-renewing. Previously this had 
only been possible by using cells from teratocarcinomas formed in vivo16. In vitro, these 
colonies were able to be induced to differentiate through the formation of embryoid bodies 
(EBs). The aggregated cells in the EB can start to differentiate into specific cell types through 
directed differentiation protocols 17. 
Pluripotent ES cells can be maintained on a layer of feeder cells when in the presence of 
serum and LIF (differentiation inhibitor that preserves the potential of the cells to contribute to 
a developing embryo). However, under these conditions the cells constitute a heterogeneous 
population18. 
Nowadays it is possible to maintain ESCs without a layer of feeder fibroblast cells using a 
defined culture medium, making them a more homogeneous population. This is because serum 
allows the expression of lineage specific genes in ESCs, creating an artificial situation where 
there is more unsteadiness in the expression of lineage specifiers versus upregulation of the 
core pluripotency network (to counteract the differentiation stimuli). Furthermore, while serum 
grown cells acquire H2K27me3 methylation and having 3000 bivalent genes (linked to 
developmental processes), 2i grown cells have only 1000, possessing an additional overall lower 
expression. Thus, cells growing in serum are composed of cells in different transcriptional 
stages, therefore being called metastable19. 
Serum and 2i transcriptional states are interconvertible between each other. However, 
some of the cells growing in serum that acquire lineage specific gene expression, although still 
showing Oct4 expression, reach a point where their differentiation potential is altered. On the 
other hand, cells grown in 2i are more stable in their expression patterns and thus preserve a 
relatively steadier differentiation  potential19.  
The basal formulation of the 2i was first described by Ying and Smith20 for neural 
commitment. This medium was further improved using a combination of the two inhibitors (2i): 
CHIR99021 together with PD0325901 plus LIF21, thus allowing the maintenance of the 
pluripotency network and self-renewal of cells without requiring the addition of non-defined 
components, giving rise to a ground state population of cells6,11,21. Furthermore, the presence 
of LIF and Wnt signalling molecules inhibit the cells to become primed epiblast stem cells 
(EpiSCs) (Figure 1). Wnt signalling is thought to be a highly conserved gene and therefore 
having some of its functions shared by invertebrates and vertebrates8. Wnt (also called Int-1) 
was one of the first genes to be identified as a putative oncogene in mice mammary tissue, and 
its description at the time extensively corresponded to the humans’ homolog transcript22. 
Furthermore, the APC gene, which is associated with digestive system tumours, has been 




Figure 1. CHIR influence on pluripotency. The figure shows how the Cytokines CHIR, LIF and 
PD influence the cell to support the maintenance of its pluripotency. CHIR signals through the 
canonical Wnt pathway allowing the induction of Wnt and pluripotency associated genes, LIF 
prompts Stat3 activation thus supporting the pluripotency network, while PD inhibits mitogen-
activated Kinase (MEK) which will ultimately inhibit MAPK pathway (Adapted from Wray and 
Hartmann, 201124). 
 
PD0325901 is a cytokine that blocks the FGF signalling by binding highly specifically to 
its receptor. FGF4 in particular acts intracellularly by phosphorylation of the MAPK/ERK 
(Mitogen-Activated Protein Kinases/Extracellular signal-Regulated Kinases) pathway. 
PD0325901 suppresses this activation trough selectively inhibiting MEK, an upstream kinase of 
the pathway25. 
CHIR99021 acts upon the beta-catenin/Wnt signalling pathway by inhibiting GSK3, 
which promotes beta-catenin degradation by phosphorylation of specific sites on the protein11. 
When added on its own, CHIR suppresses neural differentiation while inducing non-neural 
differentiation21. On the other hand, when conjugated with LIF, this blockage has been shown 
to support self-renewal10. Furthermore, in some cell lines, the stabilisation of beta-catenin in 
response to CHIR causes enhanced expression of the pluripotency factor Nanog, although Oct4 
suffers little changes26. Additionally, there is downregulation of Nodal signalling pathway 
components (smad7, lefty1 and lefty2), and the subsequent secondary upregulation of BMP4 
(Id1 and Id3, although Id2 is downregulated by 30%) along with its downstream components 
pSmad1/526,27. 
 
2. BMP signalling: BMP4 and Smads 1/5 
 
These proteins, that are responsible for initiating PGC specification, are a part of the 
transforming growth factor beta (TGFβ) superfamily and are involved in the regulation of cell 
proliferation, differentiation and apoptosis28. 
The BMP signalling pathway works through the assembly of two different receptors, type I 
and type II, upon presence of a ligand. Different ligands favour a certain combination of the 
type I and II receptors, leading to different outcomes in intracellular signalling29,30. When the 
receptors dimerize, type I receptor phosphorylates Smad1, Smad5 or Smad8, which then 
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recruits a co-Smad (Smad4) to bind to the DNA in the nucleus. Here, the heteromeric complex 
will have a transcription factor role in the cell nucleus30 (Figure 2). 
In combination with LIF, BMP4 supports pluripotency maintenance in vitro of serum-free 
ESCs by inhibiting neural differentiation (even though it potentiates other types of 
differentiation)20,31–33. In vivo, the role of BMP4 in the formation of PGCs is shown by the lack of 
PGCs in the homozygous null mutants and by a reduced founder population on the 
heterozygous mutants3. Furthermore, cultured epiblasts of BMP4 null mutants do not show 
Blimp1 expression, but if exogenous BMP4 is added, Blimp1 expression is restored34. 
Downstream Smad5 mutant embryos have ectopic PGCs although, in total, they have a reduced 
number or a complete absence of them in the base of allantois (in a dosage dependent 
manner). However Smad1 mutants lack PGCs in a non-dosage dependent manner35,36. 
 
 
Figure 2. BMP signalling pathway. When ligands are present, they attach to BMP receptor 1 
(BMPR1) and to BMP receptor 2 (BMPR2). The later will phosphorylate and thus activate BMPR1 
which will phosphorylate SMAD1/5/8. Later they will associate with SMAD4 and function as a 
transcription factor in the nucleus, regulating gene expression. (Adapted from Hardwick et 
al.37). 
 
3. Primordial germ cells (PGCS) 
 
Primordial Germ Cells (PGCs) are the cells that will mature into gametes, giving rise to 
sperm or oocytes38.  PGCS are not stem cells. Stem cells are usually defined by remaining in a 
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pluripotency state where they are able to give rise to two cells: either two identical cells to the 
mother-cell, or if they undergo asymmetrical division one identical and another that is able to 
follow some differentiation pathway. By contrast, PGCs do not self-renew and during each cell 
division (in mice they go through around 9 or 10 divisions) contributes to an advance in their 
developmental stage39. Different species have different ways of producing PGCs. PGCs can arise 
either through preformation or epigenesis.  
Preformation depends on maternal determinants (such as RNA and proteins) present in 
the germ plasm of the oocyte, which is fundamentally a specialized cytoplasm 40. For example, 
in Drosophila, the germ plasm located in the posterior part of the egg is capable of turning any 
cell of the syncytioblast into pole cells, which are cells that will later mature into the germ 
cells41. In the case of zebrafish, where there is no syncytioblast, there is an asymmetric 
distribution of cytoplasm during cell cleavage. Thus the germ plasm containing specific RNAs 
will be pushed only into four cells of the embryo, functioning as a cue for PGC development42,43. 
Epigenesis is a process whereby PGC formation is dependent on the presence of 
induction factors. It usually occurs further ahead in development, typically during gastrulation, 
when the embryo is being patterned by induction factors from surrounding tissues40.  
In animals using both processes of PGC formation, the PGCs have a migratory phase to 
the developing genital organs39,44. In mammals, the PGCs of a male individual stop proliferating 
in the G0/G1 cycle phase after they reach the genital ridges while in females the arrest occurs in 
the oocyte at the prophase stage of the first meiotic division. After the arrest, the primordial 
germ cells start the next phase of germ cell development, spermatogenesis or oogenesis39. 
 
3.1  PGCs in mouse 
 
Brambell, in 192745 described mouse PGCs as larger cells of epithelial origin, with big oval 
nuclei and two or three acidophil nucleoli. Later, Chiquoine46 used AP staining as a specific 
marker for PGCs, describing that they can be found in cells of the proximal end of the primitive 
streak (or base of the allantoic mesoderm), suggesting a mesodermal (splanchnopleuric extra-
embryonic mesoderm) origin46. Through Ginsburg47 experiments it was possible to distinguish 
at early E7 a cluster of AP positive cells in the base of the allantois. Later, PGCs increase in 
number through mitosis and migrate through the dorsal mesentery to the hindgut endoderm, 
towards the genital ridges were they will settle 48. 
 
3.2  PGC competence and specification 
 
Signals for PGCs competency start as early as E5.5, discriminating the germ cell lineage from 
the somatic lineage. The first molecular signals involved in PGCs differentiation come from the 
extraembryonic ectoderm (ExE) and from the visceral endoderm (VE). These signals belong to 
the TGF-β family: BMP4 and BMP8b from the ExE and BMP2 from the VE49–53. 
At around E6.25 BMP4 induces Fragilis to be expressed in the proximal epiblast area 
next to the extra-embryonic ectoderm, the base of the emerging allantois54. Some of the cells 
begin to express Blimp1, a protein that represses the expression of major somatic genes, like 
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Hoxb55. The ones expressing Blimp1 and a higher expression of Fragilis are associated with 
those that will latter express Stella 54 (Figure 3). 
 
 
Figure 3. Specification and migration of mouse primordial germ cells. (A and B) After 
acquiring competence to respond to ExE BMP4 as a result of Nodal and Wnt3 signalling, some 
cells will be induced to express Fragilis in the proximal epiblast. Some of these will start 
expressing Blimp1, then PRDM14 and later on Stella and will have an increase on AP activity. (C) 
At around E8 the cells will migrate from their place of formation along the endoderm, until E9,5 
when they start to migrate towards the dorsal body walls and finally, about 1 day later, they 
reach the genital ridges were they will continue to mature. (Adapted from Saitou et all, 201256). 
 
 
Blimp1 downregulates genes that are being expressed by neighboring somatic cells, like 
Brachyury T, allowing the upregulation of pluripotency genes like Nanog and Stella55. Nanog is 
detectable in the embryo in early migrating PGCs around E7.75 and it is seen co-localizing with 





Figure 4. Migrating PGCs in the E9.5 and E10.5 embryos.  (Adapted from Yamaguchi 2005) 
 
At E8.5 and until PGCs reach the gonadal ridges, the PGCs undergo major epigenetic 
remodelling. They go through DNA demethylation by downregulating the histone 
methyltransferase GLP, responsible for H3K9me2, while this is substituted by high levels of 
H3K27me3, a still repressive but more plastic methylation57. There is thus the erasure of 
existing imprints which will later be followed by the establishment of new imprinting. In the 
case of female cells, there is also the reactivation of the inactive X chromosome. These 
mechanisms therefore allow epigenetic mutations that might have occurred to be erased, but 
are important mainly to equalise the two parental epigenomes58. 
With the knowledge of these molecular signalling pathways it was possible to generate 
PGCLCs from ESCs in vitro, recapitulating the different in vivo specification steps 59. 
 
4. Primordial Germ Cells from Embryonic Stem Cells 
 
Earlier protocols for ESCs differentiation into PGCs depended on culturing ESCs with serum 
and let the cells spontaneously differentiate and after that the cells of interest had to be 
selected60–62. Some recent protocols go through a step-by-step differentiation induction, first 
obtaining EpiLCs and afterwards inducing PGCLCs4,5,34,63. 
The culturing of E6 epiblasts has shown that the ExE is capable of inducing all the cells of 
the epiblast to express Blimp1 and Prdm14 through BMP4 induction (since BMP4 null mutants 
are also capable of expressing them if induced with exogenous BMP4). Additionally, if the VE is 
removed and its inhibitory signals (like Cer1) are not present, all the cells will be receptive to 
BMP4 and have potential to express Blimp1. Alternatively, the use of BMP8b in culture restricts 
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possible BMP4 inhibitors (like Wnt or Nodal) potentiating its action34. Wnt3 however gives the 
epiblast competency to respond to BMP4 signalling, even though independently it does not 
induce Blimp1 in epiblasts34. 
When culturing isolated epiblast cells they show little Blimp1 expression but with the 
addition of LIF the epiblast becomes totally depleted from Blimp1 positive cells. LIF was found 
to inhibit a mesendoderm marker, Goosecoid (Gsc)34, which suggests that the presence of 
mesendoderm or mesendoderm determinants may be important for the induction of Blimp1 
cells, even though LIF has also been shown to support PGC survival, and in conjugation with 
Stem Cell Factor (SCF) assist in their proliferation64,65.  The combination of BMP4 with BMP8b, 
Epidermal Growth Factor (EGF), LIF and SCF was shown to be the most supportive for epiblast-
derived cells growth34. 
Hayashi and colleagues induced the differentiation of EpiLCs by adding Activin A, basic 
Fibroblast Growth Factor (bFGF) and Knockout Serum Replacement (KSR) 1% to a culture of 
ESCs grown in 2i+LIF for 2 days63. These cells showed reduction of the pluripotency markers 
Nanog by day 1 and Sox2 at day 2, while Oct4 expression remained continuous throughout. ICM 
markers (Prdm14, Zfp42, Klf2 among others) were downregulated and primitive endoderm 
markers (Gata4 and 6, Sox17 and Blimp1) underwent downregulation as well, which does not 
occur in EpiSCs. At the same time there was an increase in epiblast markers Fgf5, Wnt3 and 
Dnmt3b63. 
These EpiLCs could be induced by BMP4 alone or BMP4 plus LIF to become Blimp1 
positive (~35.3%) from day 2 on. On day 4, Blimp1 positive cells (~9.8%) formed clusters, with 
some of them also expressing Stella (~1%). On day 6, Blimp1 and Stella expressing cells became 
more restricted to the periphery. Adding BMP8b, SCF, LIF and EGF to the PGCLCs culture 
influenced only the maintenance and proliferation of the cells, with BMP4 being the major 
inducer63. 
These PGCLCs expressed Oct4 in a constant manner throughout differentiation, while 
reacquiring expression of Sox2 and Nanog. Interestingly it was possible to select this population 
through the surface markers SSEA-1 and Integrin-β3. Expression of PGC markers like Blimp1, 
Prdm14 and Stella together with downregulation of somatic mesodermal genes like Hoxa1 and 
Hoxb1 was observed63. 
The transplantation of these disaggregated sorted cells into seminiferous tubules of 
infertile male mice resulted in proper spermatogenesis of the PGCLCs, were able to produce 
fertile offspring with normal imprinting and growth63. A similar procedure was also attempted 
to achieve female gametes from PGCLCs. The cells were first aggregated with a reconstituted 
ovary, composed of the PGCLCs aggregated with female gonadal cells isolated from E12.5 
embryos, matured in vitro for 2 days and afterwards transplanted into the ovarian bursa. The 
obtained oocytes were capable of generating viable offspring after IVF (in vitro fertilisation). 
However, faulty second polar body extrusion occurs in half of the generated eggs, and overall 
success of PGCLCs to offspring was 3.9%66. 
Exploring other protocols would therefore be useful to assess the robustness of already 
described differentiation methods (for the case of directed ME differentiation) and also to 
evaluate the spontaneity of PGC developmental process.  
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II. Project Objective 
 
The aim of this study was to investigate whether it is possible to obtain more PGCLCs. A 
protocol for obtaining mesendoderm, using only the addition of CHIR (GSK-3beta inhibitor), was 
tested. This choice was based in the already published protocol by Hayashi where there is a first 
step of differentiation into epiblast like cells and only subsequently the induction of PGCLCs. 
Through adapting the Hayashi protocol, increasing the production of mesendodermal cells (that 
produce BMPs) from EpiLCs, instead of adding additional factors to the medium, in order to 
obtain PCGLCs.  
BMP4 and its downstream signaling components have been shown to play a crucial role 
in PGC differentiation. Smad5 null mice in particular have PGCs even though in a reduced 
number, but also develop ectopic PGCLCs. The second goal was thus to study the role of Smad5 
(and Smad1) in the in vitro induction of PGCs, using our proposed method.  
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Material and Methods 
 
1.  Cell Culture 
1.1 Cell lines 
1.1.1 Non-transgenic cell line E14 
Embryonic stem cell line ES-E14TG2a (E14) (ATCC, Manassas USA), derived from 129/Ola 
mice67 was used as a comparison baseline, since it has been widely used across laboratories. 
 
1.1.2 Smad5-/- Blimp:RFP 
In order to create a reporter cell line, a crossing between strain C57BL/6 Smad5 
heterozygous transgenic mice (Smad5+/-) and a C57BL/6, with a RFP protein linked to a Blimp1 
promotor, transgene (B6.Cg-Tg(Blimp1-RFP1)Rbrc) (Riken, Wako, Japan), were performed. This 
would allow to track Blimp1 expression and to compare it with Smad5 null individuals in order 
to study the importance of this molecule.  
 
1.1.3 Smad5fl/fl Smad1fl/fl and Smad5-/- Smad1-/- 
To assess the importance of downstream BMP4 signalling, a Smad1 Smad5 null cell line was 
used. The Smad5 null allele was obtained by flanking Exon2 together with a Neo-cassete, for 
Neomycin resistance selection, by loxP sites, generating Smad5flox/flox cells68. The phenocopy of 
these floxed mice is similar to that of conventional Smad5-/- mice69, displaying an abnormally 
elongated allantois with an enlarged base 70. Ectopic cells in the amnion and abnormal vessels 
were also observed, similar to what is already described for Smad5-/- mice69. Smad1 loxP 
flanked allele used was generated in a similar way as described by Tremblay71. A Cre 
recombinase-expression vector (pEFBOS-CreIRESpuro) was used for the excision of Smad1 and 
Smad5 alleles by homologous recombination72. 8x10 cells were suspended in a solution of 
750µl of phosphate buffered saline (PBS) and afterwards 10µg of Cre recombinase-expression 
vector were added. Electroporation was done as described previously by Barnett and 
colleagues73. Cells were plated and allowed to grow in 2i medium for 48h, after which followed 
another 48h of 2µg/ml puromycin selection. 96 of the selected colonies were manually isolated, 
grown in 2i and genotyped as described70,71. 
 
1.2 Mouse Embryonic Stem Cell (mESC) line Derivation 
Females were checked every morning for plugs. The midday after the plug being 
detected was considered to be embryonic day (E)0.5. Pregnant females were sacrificed at E3.5, 
and the uterus along with the fallopian tube and ovaries were isolated and placed in M2 
medium. The majority of the fat was removed and the uterus was cut under the fallopian tube 
and ovary and flushed with a syringe filled with M2 medium (Gibco, Carlsbad, USA) containing 
1% Bovine Serum Albumin (BSA) Fraction V (Gibco). Blastocysts were collected using a mouth 
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pipette and transferred to drops of KSOM+AA (Milipore, Bilerica, USA) with phenol red medium 





After incubation for 24h at 37ºC and with 5% CO2, the E4.5 blastocysts were treated with 
Tyrode's acid, while pipetting up and down, to remove the zona pellucida (ZP) (Figure 5B) and 
plated for 3 days in organ dishes, previously coated with 1% porcine skin gelatine, with N2B27 
containing 2i + LIF to allow the cells to proliferate (Figure 5C) The N2B27 medium is described in 
detail in Table 3). The ICM outgrowth was picked, washed in 3 drops of PBS and incubated in 
0.25% trypsine/EDTA for about 5 minutes followed by pipetting up and down in order to obtain 
single cells. Thereafter, the single cells were seeded in a 1.9 cm2 organ dish, previously 
gelatinized, until the colonies are big enough to trypsinize again (passage 1) (Figure 5D). After 3 




Figure 5. Representative scheme of a cell line derivation from blastocysts. (A) Blastocysts in 
a drop of KSOM medium. (B) Detachment of the zona pellucida (here represented by the 
yellow color) after treatment with Tyrode’s acid   (C) Growing ICM of the cultured blastocyst in 
N2B27+2i+LIF.  (D) Single cells after picking and trypsinization will grow into colonies. The 




In order to identify the derived cells genotype, these were directly collected from culture 
and subsequently lysed. The lysis was performed with a Proteinase K (Promega, Wisconsin USA) 
solution specified bellow (Table 1). The cells were kept in a shaker with the lysis solution for 2 
hours at 55ºC at 750 rpm. The temperature was raised up to 96ºC for 10 minutes to inactivate 
the enzyme. For amplification of the queried transgenes the biological material was submitted 
to PCR. The PCR mix was prepared with SilverStar DNA polymerase (0,4μL of enzyme, 2,5 μL 10x 
reaction buffer, 2,5 μL of dNTPs 2,5mM each, 0,5 μL of each primer, 1 μL MgCl2 and 16,6 μL of 
H2O) (Table 2). The primers used were designed to amplify Smad5 (3’-
TCTGGCCTCTTAATCCTGGACTTTCC-5’, 5’-GAGACTAGTGAGACGTGCTACTTCC-3’ as well as the 
Smad5 KO sequence (5’-AAGAGAGTGGAGAGTCCAGGTAAG-3’, 3’- 
ATGCAAATTGGGGAGGTACACGTT-5’)74, and RFP (5’- CGAGGACGTCATCAAGGAGT-3’, 3’- 
CTTGGCCATGTGTAGGTCT -5’), with expected band sizes of 700bp, 520bp and 541bp, 
respectively.  
 













Table 2. PCR programs for the Genotyping primers. 
Smad5 RFP UBEX 
Temperature Time (min) Temperature Time (min) Temperature Time (min) 
94º C 03:00  94º C 03:00  94º C 05:00  
94º C 00:15 Repeat 
38x 
94º C 00:30 Repeat 
34x 
94º C 00:15 Repeat 
34x 60º C 00:45 60º C 00:30 64º C 00:20 
72º C 00:45 72º C 00:30 72º C 01:00 
72º C 07:00  72º C 05:00  72º C 07:00  
 
 
Lysis buffer Proteinase K 
Component Concentration Volume Component Concentration Volume 
KCL 3M 3,3 ml Tris-HCL (ph8) 1M 100 µl 
Tris-HCL (ph8.3) 1M 2,2 ml CaCl2 1M 200 µl 
Gelatin 1mg/ml 20 ml Glycerol 100% 5 ml 
NP40 - 900 µl MQ - 5 ml 
Tween 20 - 900 µl ProtK - 100 mg 
MQ - 172.6 ml 
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1.2.2  Agarose gel Electrophoresis 
The products of genotyping PCR were later submitted to electrophoresis in an agarose 
gel (UltraPure Agarose, Life Technologies Carlsbad USA). This technique was used in order to 
separate bands and visualise PCR reactions. Agarose was used mostly at 1.5% concentration in 
1x TAE. Ethidium bromide was added in 0.2μg/mL concentration, which allowed visualisation of 
the bands under UV light owing to its DNA intercalating and fluorescent properties. Loading 
buffer was added in a proportion of 1:6, loading buffer to sample DNA, to allow visualisation of 
band migration during electrophoresis with the naked eye. Additionally, a 1Kb DNA ladder was 
added to the gel to estimate fragment size and left running for approximately 40 minutes at 
100v of power. The agarose gel was imaged with AutoChemi System UVP (Bioimaging Systems). 
1.3  Splitting 
The mES cells were maintained in the ground state with a modified version of the classical 
N2B27 (Table 3). As described previously by Ying et al. (2003)20, supplemented with 1 µM 
PD0325901 (STEMGENT, Cambridge, USA) and 3µM CHIR99021 (Axon-Medchem, Groningen, 
Netherlands), together called as 2i (2 inhibitors) and 2000 U/ml of mouse Leukemia Inhibitory 
Factor (mLIF) (ESGRO Millipore, Billerica, USA) at a density of 30.000 cells per cm2. Medium was 
refreshed every day and cells split every other day. The wells were previously coated with 0.1% 
of porcine skin gelatine for 1 hour at room-temperature (RT) or 30 minutes at 37oC in the 
incubator. Cells were cultured under controlled environment of an incubator, at 37 ºC, with 5% 
CO2 and 20% O2. 
The splitting consisted in washing the cells 3 times with PBS 1X, incubating them for 3 
minutes in 0.05% tryspsin/EDTA gently tapping the culture plate.. This step was followed by 
trypsin inactivation through addition of N2B27+2i+LIF medium and by collection into a falcon 
tube. The cells were then centrifuged for 3 minutes at 1100 rpm, the supernatant was removed 
and they were ressuspended in 1 ml of N2B27+2i+LIF. The cells were then passaged 1:10 or 
counted using a Neubauer hemocytometer. 
 
1.4  Cryopreservation 
In order to keep a stock of the mESC lines they were routinely cryopreserved at least once 
per week. After trypsinisation, mESC were centrifuged, the supernatant discarded and 
resuspended in 500 µl of culture medium after which 500 µl of freezing medium (60% regular 
medium, 20% FCS and 20% DMSO) was added. The mESC (Cryo.s™ Greiner Bio-One) were either 
stored in the -80oC for 2 to 3 months or stored in the liquid nitrogen for longer term. 
1.5  Thawing 
For thawing of the cells, the vials were immediately put in the water bath at 37oC until it 
was possible to distinguish only a small pellet of frozen medium inside the cryovial. Afterwards 
the cryovial content was transferred to a falcon, centrifuged for 3 minutes at 1100 rpm, 





Table 3. Comparison of the components of N2B27+2i+LIF by Ying (2003) and the modified 
version of the N2B27 used for this study. 
N2B27+2i+LIF Modified N2B27+2i+LIF 
Insulin 12.5 μg/ml Insulin (N-2 Supplement (100X) 
liquid) 
5 μg/ml 
DMEM/F-12+GlutaMAX  0.5 x DMEM/F-12+GlutaMAX 0.5 x 
Neurobasal  0.5 x Neurobasal (Invitrogen) 0.5 x 
Penicillin/Streptomycin 25 U/ml Penicillin/Streptomycin 25 U/ml 
B27  0.5 x B27 (50x, Invitrogen) 1 x 
Apo transferine 50 μg/ml Holo Transferine (N-2 
Supplement (100X) liquid) 
100 
μg/ml 
BSA fraction v 7,5%  0.0025% BSA fraction v 7,5% (Invitrogen) 0.5% 




Putrescine 8 ug/ml Putrescine (N-2 Supplement 
(100X) liquid) 
16 ug/ml 
Sodium Selenite 0.015 μM Sodium Selenite (N-2 Supplement 
(100X) liquid) 
0.033 μM 
BME 90 μM BME 100 μM 
2i+LIF 
CHIR99021 3 μM CHIR (Biovision) 3 μM 
PD0325901 0,4 μM PD (Stemgent) 1 μM 
mLIF 1000 U/ml LIF (Milipore) 2000 
U/ml 
 
1.6  Differentiation Media experimental design 
mESCs were plated at 10 000 cells per cm2 on day 0 (D0) of the experiment either in N2B27 
alone (Figure 6A and 6B) or in Mouse Embryonic Feeder, MEF, medium (Figure 6C), constituted 
by DMEM 41966 (Life Technologies), 10% FCS, 0,5% Penicilin/Streptomycin, 1% non-essential 
amino acids and 0.1mM BME. After 2 days (D2), when the cells became competent to respond 
to differentiation signals75, the media was refreshed: the set of the cells growing in N2B27 was 
refreshed with N2B27 containing 3µM of the inhibitor CHIR99021 (from here on also called C 
medium) and the other set with N2B27 alone (from here on also called N medium), while cells 
in MEF were refreshed with the same medium (from here on also called M medium). They were 
left to differentiate for 4 more days, for a total of 6 days (D6). At D6, the cells were either 






2.  Alkaline Phosphatase staining 
Alkaline phosphatase was performed as described previsouly76. Brief cells were fixed in a 
coverslip for 2 hours at 4ºC temperature in 4% PFA, washed 3 times with PBS, kept for 1 hour in 
70% EtOH at 4ºC, followed by 3 times PBS wash and treated with the alkaline phosphatase 
reaction solution (Table 4). Enough solution was used to completely cover the bottom of the 
well. Cells in the staining solution were observed under the magnifier; the staining was 
evaluated by eye and stopped with tap water when a strong red colour was achieved. The final 
mounting was done in 70% glycerol.  
 
Table 4. Components of the alkaline phosphatase aqueous solution reaction. 
Component Percentage in Solution µl 
Veronal 1% 500 
Magnesium Chloride 0.12% 500 
Fast RED 1 mg/ml 500 
Sodium α-Naphtyl phosphate 0.02 mg/ml 500 
Distilled water - 3000 




Figure 6. Conditions used for the 6 day differentiation of the mESCs cell lines. The media 
used in treatment (A) Mesendoderm (ME) medium for the differentiation of the cells into 
mesendoderm-like cells with the addition of CHIR. Treatment (B) Neuronal (NE) medium. 
N2B27 alone has been shown to promote neuronal differentiation. (C) Spontaneous 
differentiation medium using regular MEF cells medium. 
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3. Analysis of gene expression 
 
3.1  RNA isolation and cDNA synthesis 
Cells were collected as a dry pellet obtained through centrifugation and removal of the 
supernatant. RNA was extracted using the RNeasy Micro Kit (Qiagen) and following the 
manufacturer’s instructions. The concentration and the purity of RNA were determined after 
RNA extraction using the NanoVue Spectrophotometer (GE Healthcare Life Sciences, Piscataway 
USA) and the QuBit Fluorometer (Life Technologies, Carlsbad USA).  
Reverse transcription cDNA was synthesized with Bio-Rad iScript™ cDNA Synthesis Kit 
(BioRad, California USA) according to the manufacturers protocol (Table 5). As a control for 
DNA contamination the amplification of the cDNA by PCR was also performed without the 
reverse-transcriptase. 
 
Table 5. Reverse transcription reaction mix and PCR program. 
Reaction Mix iScript™ PCR program 
5x iScript reaction mix Temperature Time (min) 
Nuclease free water 25ºC 05:00 
Up to 1 μg RNA 42ºC 30:00 
iScript reverse transcriptase 85ºC 05:00 
 
3.2  Quantitative reverse-transcriptase PCR (QPCR) 
The relative amount of a target gene present in a sample was assessed with SYBR green® 
fluorophore PCR analysis. For one reaction, a primer mix for each gene was prepared with 10μl 
SYBR green® and 0.5 μl of the forward and reverse primers.  The template mix was prepared 
with 3 μl of template cDNA diluted in 8μl of mQ water (Table 6A). The reaction was set in a 96-
well plate (BioRad) on a PCR cooler (Eppendorf®) with 9μl of template mix and 11μl of the 
primer mix in each well. All the samples were analysed in triplicate together with the respective 
negative control (without the reverse transcriptase) and expression was normalised relatively 
to the geometric average of two house-keeping genes GAPDH (5´-TGCACCACCAACTGCTTAGC-
3’, 3’-GGCATGGACTGTGGTCATGAG-5’) and β-actin (5’ -CCT GAA CCC TAA GGC CAA CCG-3’, 3’-
TGT AGC CAC GCT CGG TCA GGA-5’) using the ΔΔCT method77. Adhesive PCR film (Eppendorf®) 
was used to cover the plate, which was afterwards centrifuged to remove any bubbles that may 
have formed during the pipetting process and could disturb the fluorescence signal reading. 
The plate was then inserted in a C1000 thermal cycler (BioRad) (Table 6B). The primers used are 





Table 6. A. Components used for the QPCR reaction mix solution and B. corresponds to 







Table 7. QPCR primers sequence. 
Gene 
Primer 
Product size (bp) 
Forward Reverse 
Oct4 TTCTAGCTCCTTCTGCAGGG AGAGGGAACCTCCTCTGAGC 115 
Stella CGGGGTTTAGGGTTAGCTTT GGACCCTGAAACTCCTCAGA 110 
Blimp1 TAGACTTCACCGATGAGGGG GTATGCTGCCAACAACAGCA 96 
Nanog CTTTCACCTATTAAGGTGCTTGC TGGCATCGGTTCATCATGGTAC 112 
GAPDH TTGATGGCAACAATCTCCAC CGTCCCGTAGACAAAATGGT 110 
ACTB ACCATGTACCCAGGCATTG TACTTGCGCTCAGGAGGAG 101 
 
 
4.  Immunostaining 
For immunostaining cells were grown on glass coverslips coated with 0.1% gelatine. Then 
they were fixed in 4% Paraformaldehyde (PFA), permeabilised in 0.1% Triton X-100 in 
phosphate-buffered saline (PBS) and blocked in 0.05% tween-20 in PBS containing 2% BSA. The 
primary and secondary antibodies were applied in blocking solution with 1% BSA, overnight at 
4oC and 1 hour at RT, respectively. The secondary antibody was washed 3 times with PBS 1X. 
Nuclei were stained with DAPI (1:1000) for 1-2 minutes and washed 3 times with PBS 1X 5 
minutes each. Finally the coverslips were mounted on a slide with 5µl of antifade mounting 
medium (Prolongold), left to dry overnight and sealed with nail polish. 
The primary antibodies used were the following: Oct4 (1:200, Oct-3/4 Antibody (N-19): sc-
8628), Nanog (1:200, ab80892, Abcam), Sox17 (1:200, AF1924, R&D systems), Brachyury-T 
B. Reaction Mix 
Primer 
Mix 
10 µl SYBR green® 
0.5 µl Forward primer (10mM) 
0.5 µl Reverse Primer (10mM) 
Template 
Mix 
8 µl mQ water 
1 µl Template cDNA 
Total 20 l 
A. QPCR program 
Temperature Duration 
95oC 3 minutes 
95 oC 15 seconds 
Repeat 40x 60 oC 1 minute 
72 oC 30 seconds 
72 oC 10 minutes 
Melt curve: 65 oC  to 
95 oC 
0.5 oC  each 5 seconds 
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(1:200, AF2085, R&D systems), β-catenin (1:200, 610153, BD Biosciences). All the Alexa Fluor 
secondary antibodies (Invitrogen) were used at 1:500 dilutions. 
 
5.  Imaging 
Pictures of the stained cells were obtained with Leica microsystems DM5000 microscope 
and pictures produced with imageJ and photoshop CS6. 
 
6. Statistical Analysis 
Statistical analysis of the QPCR values was performed with STATISTICA. Mann-Whitney test 
was used to calculate if there is a pairwise difference between the distributions of the three 





1. Effects of cell density during mesendoderm (ME) differentiation 
 
Culture conditions influence cell behaviour extensively and density in particular influences 
the differentiation ability of cells78. Our objective in this study is to have a simpler way to 
differentiate PGCLC, thus we first investigated if cell density would play an important role 
during the 6 day differentiation towards PGCLC in E14 cell line.  
CHIR has been shown to augment beta-catenin (canonical Wnt signalling) which on its 
turn downregulates Nodal signalling allowing the subsequent upregulation of BMP4 and 
phosphorylation of Smad1 and Smad59,27, which are important factors for PGC 
specification36,49,79. In addition, Wnt signalling enforced by CHIR was also shown to direct cells 
into meso/endoderm-specific differentiation in a more homogeneous manner when cultured in 
a monolayer (when compared with EB differentiation)13.  
We tested different monolayer densities to assess the efficiency of the mesendoderm 
(ME)-differentiation protocol: 1 × 104, 2 × 104 and 3 × 104 of E14 mESCs per cm2. The density of 
2 × 104 and 3 × 104 cells/ cm2 were shown to be the optimal density for regular feeder-free cell 
passaging, higher densities resulting in cell death and lower concentrations found to block cell 
proliferation66.  
We observed AP-positive clusters (presumably PGCLCs clusters) only when the cells 
were seeded at a density of 1 × 104 cells/cm2 (Figure 7A). At higher density, AP-staining was 
reduced to background levels and most of the differentiated cells displayed a flattened 





Figure 7. Alkaline phosphatase staining of E14 mESCs after 6 days of ME-differentiation.  The 
cells were plated at different initial densities: (A) 1 × 104 cells/cm2 is the only condition that 







2. ME markers are upregulated in E14 after 6 days ME-differentiation  
It is known that Wnt signalling pathway (inhibition of GSK-3β) not only promotes self-
renewal in mESCs when combined with PD and LIF but is also capable of inducing cells to 
become ME progenitors81. When E14 mESCs are induced to differentiate through inhibition of 
GSK-3β, after 7 days, the cells begin to express T-brachyury, Sox17, Gata2, Nkx2.5, Hand1, 
Foxa2, AFP and Gata481. The first two, the core mesodermal regulator Brachyury-T and 
endodermal Sox17 will be examined here by immunofluorescence together with Nanog. The 
latter is a pluripotency factor which is required to decrease in order to allow the cells to evade 
the pluripotency network loop, allowing differentiation to occur (later emerging again in 
migrating PGCs82). 
In E14 ESCs differentiated for 6 days in MEF medium (spontaneous differentiation), it is 
possible to distinguish some cells expressing SOX17 (endoderm marker) and BRACHYURY-T 
(mesoderm marker) and some NANOG positive cells (Pluripotency or presumptive PGCLCs). 
However, mESCs differentiated to ME showed high levels of SOX17 and BRACHYURY-T 
compared to spontaneous differentiation and neurectoderm (NE) differentiation. Moreover, 
the number of NANOG positive cells in ME-differentiation condition was higher and 
concentrated in larger NANOG-positive clusters, suggesting a higher number of presumptive 
PGCLCs (Figure 8A). 
 
3. PGC markers are upregulated in E14 after ME differentiation 
The analysis of certain lineage markers would permit to distinguish whether the 
differentiated mESCs have differentiated into PGCLCs (when expressing Blimp1 and/or Stella, 
but also expressing pluripotency markers Nanog and Oct4) or other lineages (no expression of 
the pluripotency markers Nanog, Oct4, Stella, but eventually Blimp1 which is expressed by 
endoderm cells as well). 
Using QPCR, the relative expression of Oct4, Nanog, Blimp1 and Stella, after 
normalisation to the house keeping genes GAPDH and beta-actin, was studied. We expected a 
slight increase in PGC markers because it is expected that cells becoming ME will be the 
majority of cells and only a few will become PGCLCs, since in the ME-inducing protocol the yield 
of PGCs was also relatively low (8% at 4 days of culture after Blimp-positive cell selection which 
occur in 21% of the cells, giving a yield of approximately 1.6%4).  
In differentiated E14 cells, Oct4 and Nanog decreased using all 3 differentiation 
protocols suggesting loss of pluripotency83,84. However, in the ME-differentiation, the E14 
retained higher Oct4, Nanog and Blimp1 expression and most importantly, the ME-protocol 
resulted in the strong upregulation of Stella, suggesting increased differentiation to PGCLCs. 
The induction of ME could indeed increase the production of PGCs during differentiation of E14 





















Figure 8. Immunostaining and QPCR of E14 cells after 6 days of differentiation. (A) In the 
MEF condition (spontaneous differentiation) there are few cells expressing NANOG while 
SOX17 and T are not expressed. In N2B27 condition (NE-differentiation) there is also 
expression of NANOG while the mesendodermal markers are absent. The N2B27+CHIR 
condition (ME-differentiation), the condition expected to generate mesoderm and endoderm 
in larger quantities, shows expression of SOX17 and BRACHYURY-T in addition to NANOG. 
Scalebar is 100µm. (B) Relative expression of pluripotency and PGCs markers in E14 cells 
after 6 days ME-differentiation. Expression values were normalised to expression of 
housekeeping genes and are shown in relation to undifferentiated mESC in the 2i condition. 
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4. Derivation of Smad5 KO Blimp1:rfp mESCs lines 
After developing a protocol that allowed differentiation to PGCLCs after 6 days (ME-
differentiation protocol), we investigated the role of Smad5 in differentiation to PGCLCs in vitro 
using a Smad5 KO Blimp:rfp mouse model. For this, we attempted to derive Smad5 KO 
Blimp:rfp mESC lines. We derived three independent mESC lines (from three different embryos, 
resulting of a crossing between Smad5+/- Blimp1+/- male mouse with a Smad5+/- female mouse), 
that were named 1.2 (Smad5 WT), 1.3 (Smad5 KO) and 1.4 (Smad5 Het), but none of the lines 
expressed the Blimp1:rfp transgene. 
The genotype of each of the newly derived ESC line was determined by genomic PCR using 
Smad5 and RFP specific primers. To visualise the amplification products the samples were 
loaded in an agarose gel and submitted to electrophoresis (Figure 9). 
 
Figure 9. Genotyping of mESC lines. Determination of which transgene is carried by each 
cell line is depicted in the gels in addition to the sex assessment of the cell lines. Cell line PCR 
product bands are indicated with 1.2, 1.3 and 1.4 above their respective lanes.  (A)  Agarose gel 
containing Smad5 KO PCR products, with a band size of 520bp. K.O. lane serves as a positive 
control as it contains material from a previously confirmed Smad5+/- mouse. WT lane represents 
the negative control. (B) Gel for Smad5 WT gene, with a size of 700bp. K.O. and WT lanes are 
both positives controls. Since the K.O. mouse used for control was heterozygous it also has a 
band for the Smad5 WT gene. (C) Gel containing RFP PCR products of 541bp of length. RFP+ and 
RFP- are positive and negative controls, respectively. The control DNA used was from mice 
previously tested for the RFP gene. (D)UBEX PCR for assessing the cells sex chromosomes. 
Males, which contain XY sex chromosomes, have two bands, one for the X chromosome (with 
217bp of length) and another for the Y chromosome (with 198bp) while females have only one 
band corresponding to XX sex chromosomes. The lane where mQ is indicated is a control for 
contamination and instead of biological material, H2O was added to the PCR mix. In all gels a 




Despite the derivation efforts, no Smad5 KO mESCs line containing the Blimp1:gfp reporter was 
generated (Figure 9 and Table 1). 
 
 
Table 1. Genotyping final results of transgenic cell lines. 
Cell line UBEX Smad5 K.O. Smad5 WT RFP 
Smad5 KO*Blimp:RFP 1.2 ♀ - + - 
Smad5 KO*Blimp:RFP 1.3 ♀ + - - 
Smad5 KO*Blimp:RFP 1.4 ♂ + + - 
 
5. Derivation of Smad5 and Smad 1 KO mESCs lines 
As we were unable to derive Smad5KO Blimp1:rfp mESCs, we decided to use a double 
Smad1/5 mutant mESCs instead of the single Smad5 KO, since we no longer had the advantage 
of having the Blimp1:rfp. 
 
 
5.1 ME markers are upregulated in Smad1fl/fl Smad5fl/fl WT mESCs  
 
The results from ME-differentiation protocol Smad1fl/fl Smad5fl/fl WT mESC line showed 
NANOG-positive cells with neighbouring SOX17 positive cells, in a tight structure (Figure 10A). 
The latter, similar to the results obtained for E14 cell line, suggests the presence of PGCLCs 
after 6 days of ME-differentiation. Mesoderm (BRACHYURY) was also successfully induced in 
the ME protocol and resulted in a typical elongated structures of mesoderm. Although the 
other differentiation protocols were able to induce mesendodermal marker expression as well, 
there were relatively less expressing cells and NANOG cells did not display a cluster-like 
structure (Figure 10A).  
As for the PGC markers studied by QPCR, our analysis showed no Stella expression but 
instead an increase in Blimp1, suggesting that they are differentiating towards mesendoderm 
or PGC precursors (Blimp1 positive/Stella negative) (Figure 10B). This also indicates that the 
cells likely require a protocol adjustment, for example differentiation during a longer period. 
 
 
5.2 ME markers are upregulated in Smad1-/- Smad5-/- KO mESCs  
 
Although we do not expect to see Stella expressing cells in ME-differentiated Smad1-/- 
Smad5-/- KO mESCs, we still wanted to assess the capacity of the KO cells to differentiate into 
mesendoderm. Thus, we tested 3 different Smad1-/- Smad5-/- KO mESCs lines for 6 days ME-
differentiation. After immunofluorescence, we observed the presence of endoderm (SOX17-
expressing cells), but less than in the Smad1fl/fl Smad5fl/fl WT mESC (except for Smad1-/- Smad5-/- 
KO 1.35). Furthermore the induction of mesoderm (BRACHYURY-T) was similar to that of the 
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Smad1fl/fl Smad5fl/fl WT mESC line, only 1.27 cell line showing relatively less induction of 
mesoderm (Figure 11). The BRACHYURY-T positive mesoderm formed typical elongated 
structures. The results suggest that the different Smad1-/- Smad5-/- KO mESCs are all sensitive to 
ME-differentiation, however the level of differentiation differed per cell line. TGF-β and Wnt 
signalling pathways have been shown to be very important for the induction of endoderm and 
mesoderm, through the canonical β-catenin pathway and through BMP proteins, respectively 
(which is stimulated by the use of CHIR). 
 
In sum, for both control E14 and Smad1fl/fl Smad5fl/fl WT mESC cell lines, the 
immunostaining confirmed the presence of mesoderm and endoderm cells in the ME-inducing 
protocol. It is also possible to discriminate NANOG positive clusters with surrounding endoderm 
(SOX17) in both E14 and Smad1fl/fl Smad5fl/fl WT mESC, which suggests the formation of a 
PGCLCs cluster. However, the latter was not confirmed by QPCR in the Smad1fl/fl Smad5fl/fl WT 
cell line, as upregulation of Stella was not observed. Blimp1 expression was observed 
suggesting that PGC progenitors could be present after ME-differentiation.  
Different mESCs have different capacities and lineage preferences for differentiation. 
This is strongly dependent on the genetic background. E14 are from 129 genetic background 
and Smad1fl/fl Smad5fl/fl WT mESC from Bl6 genetic background. This difference could explain 
the difference in capacity or efficiency to differentiate to PGCLC. We suggest that when using 
the Smad1fl/fl Smad5fl/fl WT mESC, the ME-protocol could be used for a longer period of time to 
see whether this would result in the upregulation of Stella. 
Regarding the ME-differentiation of Smad1fl/fl Smad5fl/fl KO mESC lines, it was proven 
effective. However, endoderm is relatively less (SOX17) and NANOG cells (potential PGCLCs) 
appear dispersed and not in a tight cluster (with the exception of line 1.35), which would be the 
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Figure 10. Immunostaining and QPCR of Smad1fl/flSmad5fl/fl WT cells after 6 days of 
differentiation. (A) The ME-differentiated cells showed formation of mesendoderm with a tight 
cluster of NANOG cells (potential PGCLCs). Spontaneous differentiation (MEF medium)  resulted 
in formation of endoderm, few mesoderm and NANOG cells. NE-differentiation (N2B27 media) 
resulted in only a small amount of endoderm and mesoderm cells and dispersed cells expressing 
NANOG. Scalebar is 100µm. (B) Relative expression of pluripotency and PGCs markers of 
Smad1fl/flSmad5fl/fl WT cells after 6 days of ME-inducing protocol. Expression values were 
normalised to housekeeping genes and are relative to the mESC in 2i condition. Raw ct values 















Figure 11. Immunostaining of Smad1-/-Smad5-/- KO cell lines after 6 days ME-
differentiation. KO cell lines are able to produce mesendoderm and NANOG-positive cells. KO 






1. ME-differentiation protocol vs Hayashi-protocol  
A protocol published by Hayashi et al. (Hayashi-protocol) described the differentiation 
from mESCs towards PGCLCs in a step wise manner, using Blimp1 and Stella to evaluate the 
presence of PGCLCs. However this protocol is still to be successfully reproduced in independent 
labs. We exploited a slightly different protocol, similarly resorting to a step wise differentiation, 
in order to evaluate if it is possible to differentiate PGCLCs and, if so, to compare efficiency 
between both protocols. In the Hayashi-protocol there is a first step of two days of induction 
towards an epiblast-like state which relies in induction by the growth factors Activin A, basic 
fibroblast growth factor (bFGF). We subtitute this first step by a simpler step, inducing exit from 
the pluripotency core network feedback loop and enabling the cells to become receptive to 
further differentiation cues.  
For the induction of PGCLCs per se in the established protocol, GK15 medium 
supplemented with BMP4, BMP8a, Stem cell factor (SCF), LIF and epidermal growth factor (EGF) 
was used. In our protocol we used the addition of CHIR, since it has been described to induce 
differentiation of mesendoderm. Additionally it has been shown to indirectly induce BMP4 and 
consequent downstream targets (Smad1 and Smad5) through the inhibition of Nodal signalling 
(Id1 and Id3)9. 
Our hypothesis is that the ME-differentiation by CHIR would be suficient to induce also 
the formation of PGCLCs through factors secreted by the newly formed mesendoderm. Using 
the E14 mESC line, we succeeded in developing an alternative protocol, without the need of 
expensive growth factors but relying on factors secreted by the cell-differentiating cell culture 
that resulted in the induction of PGCLCs. In addition, our ME-differentiation protocol took 6 
days, the same time period as the one reported by Hayashi et al.  
 In the Hayashi-protocol, the second step consisted of differentiation in embryoid bodies 
(EBs). EBs are multicellular structures constituted by a heterogeneous population of 
differentiated cells. In these multicellular aggregates it is difficult to control and understand 
differentiation20. On the other hand, differentiation in monolayer, despite displaying a larger 
amount of cell death, allows a higher differentiation efficiency85. Our protocol used 
differentiation in monolayer and this may prove an additional advantage to the Hayashi-
protocol towards a more defined differentiation protocol. 
 
2. Induction of PGCLCs using the ME-differentiation protocol 
 
PGCs have a specific expression timeline, thus sorting cells by FACS using Blimp1, Stella, 
CD61 and SSEA1 positive cells to select for potential PGCLCs (since, as reported by Hayashi1, 
they are sufficient for selection at culture day 4) would allow to discern if and when these cells 
are present. Analysing the selected cells for early PGC markers, like Prdm14 and Nanos3, and 
the remaining cell population after FACS selection (absence of either Blimp1, Stella, CD61 or 
SSEA1) for epiblast markers, Fgf5, Wnt3 and early Mesendoderm commitment genes (e.g. 
Goosecoid, Mixl1 and Eomes) would provide further insight. Furthermore, analysing neuronal 
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genes like Sox1 and Pax6, would allow understanding if the cells are only committing to the fate 
of epiblast cells or if they are also able to differentiate into other lineages. Other factors to 
monitor along their differentiation would include the late PGC genes Ddx4 and Dazl86.  
Even though the expression of Blimp1 is not dependent on the presence of Smad1/5, it 
would also be interesting to study BMP4 expression in the ME condition. Since BMP4 depleted 
mice have been shown to carry several defects in PGC formation14. This evaluation would also 
allow to see if CHIR is indirectly influencing the BMP4 expression as seen in the study by Wu9. In 
addition, it would also be interesting to look at the X chromosome inactivation, staining the 
cells for H3K9me2 and H3K27me3 and evaluating whether the cells differentiating are following 
similar epigenetic modifications to PGCs. 
The QPCR results showed low levels of Oct4 and Nanog transcripts in ME-differentiated E14 
mESCs, which translates the differentiating state of the majority of the cells. Oct4 has been 
shown to be a transcription factor speciffically expressed in the cells commited to the germline 
lineage87. Epiblast cell differentiation is accompanied by repression of Oct4, while PGCs 
maintain Oct4 expression due to Germ Cell Nuclear Factor (GCNF)88. Thus the only cells 
expected to continue to express these factors at this point would be the PGCLCs. Moreover, a 
FACS selection with other markers (CD61, SSEA-1, Blimp1 and Stella) for PGC selection would 
help confirm the presence of PGCLCs. 
In E14 cells, there was an increased expression of Stella (more commonly known as 
Dppa3). Stella is expressed in pre-implantation embryos and by the founder population during 
the specification of germ cells around E7.2554,89. Prior to fertilisation Stella accumulates in the 
cytoplasm. It is a maternally inherited gene and although it has not shown to carry significant 
deficiencies in germ cell specification or development, it results in preimplantation 
developmental issues when it is not inherited from the mother. Stella has also been shown to 
cause fertility reduction at different levels according to the strain of mice90 which can explain 
the differences seen in the results obtained from our different cell lines. Testing these factors 
after FACS selection from different time-points would provide more evidence. However the 
expression of Stella together with the observation of Nanog clusters points to the idea that the 
ME-protocol is indeed generating PGCLCs in E14’s after 6 days of differentiation. 
In E14 mESCs, all differentiation protocols used resulted in the induction of mesoderm, 
endoderm markers as well as NANOG-positive, presumably PGCLCs. However, there were 
relatively more mesoderm and endoderm cells in the ME-differentiation protocol and it is also 
possible to distinguish tighter clusters of NANOG-positive cells in this condition. Moreover the 
ME-differentiation resulted in upregulation of STELLA-positive cells, indeed suggesting the 
presence of PGCLCs in culture.   
In addition, E14 mESCs showed robust expression of both T and Sox17 and PGCLS induction 
(upregulation of Stella) in the ME-differentiation protocol, in contrast to the other used 
differentiation protocols (NE-differentiationa and spontaneous differentiation). However, the 
Smad1fl/fl Smad5fl/fl WT mESCs showed upregulation of Blimp1, a marker of PGC progenitors 
(and endoderm) but not of Stella, after 6 days differentiation to ME. The two mESC have 
different genetic backgrounds and it is a known phenomenon that different genetic 
backgrounds influence the capacity of different mESC to differentiate to different cellular 
lineages.  To prove this, we recommend the derivation (or use) of additional mESC lines from 
129 background and Bl6 background to clarify this issue. Furthermore, it could be that mESCs 




3. Role of (BMP) Smad1/5 signalling during PGC development  
BMP4 is a pleiotropic protein that has many roles during embryogenesis91, it supports 
for example chondrogenesis92 and the nervous system development 93. Activin, Wnt and BMP4 
signalling have also been shown to induce cardiac mesoderm and cardiomyocytes with an 
efficiency of >60%94. This differentiation leads to a population constituted by 50% 
cardiomyocytes and a few (<1%) cells committed to the hematopoietic lineage, after 7 days of 
culture94. PGCs and specific hematopoietic lineage cells, as well as the vascular system in the 
yolk sac are closely related to each other and it has been shown that they require the same 
signalling factors for differentiation95. In conclusion, it is possible that the inefficiency seen in 
differentiating PGCs of former protocols is due to the fact that cells are more likely to 
differentiate into cardiac mesoderm or hematopoietic lineage and that PGCs are actually arising 
as a consequence of the heterogeneity and secreted molecules from these cells rather than 
being differentiated as a result of the molecules used for inducing differentiation.  
 Downstream elements of the BMP signalling pathway like Smad1 and Smad5, involved 
in PGC induction, are also involved in hematopoietic development. Smad5 depleted mice have 
abnormal vasculature development69. These Smad5 depleted embryos, besides having ectopic 
PGCLCs arising from the amnion, have ectopic vasculogenesis and hematopoiesis in the same 
area (possible result of ectopic allantois tissue)79. Although cells are lacking Smad5, they are still 
able to differentiate into PGCs (although only a reduced number) and into ectopic PGCLCs69. 
This would be consistent with the presence of Blimp1 instead of Stella in our WT cell line, 
meaning that these cells are expressing Blimp1 because they are differentiating into mesoderm. 
Regarding the effects of Smad1, they are difficult to assess due to the embryos early 
lethality that result from anomalies in the chorion and allantois. However, in zebrafish, BMP 
downstream signals Smad1 and Smad5 are known to be involved in several steps of 
hematopoietic development, each assuming distinct functional roles96. Furthermore, several 
mutations along the signalling pathway components have resulted in hematopoietically 
hindered mutants (anemic embryos) and the importance of BMP signalling for embryonic 
hematopoiesis is known to be conserved in vertebrate embryos96.    
One of the goals of this study was to derive a cell line that would enable us to study 
Blimp1 one of the first known proteins to be expressed in PGCs in real time during 
differentiation of mESCs to ME and studying the role of Smad5 in this process. This would allow 
us to determine the significance of Smad5 (and consequently BMP signalling) as a major PGC 
inducer as well as to see the effects of Smad5 absence when using the ME-differentiation 
protocol. Unfortunately, despite several attempts, it was not possible to obtain Smad5 KO 
mESC with the Blimp1:rfp transgene. Nevertheless, a double-null mESCs line for Smad 1 and 
Smad5 was further used in this study.  
 Different Smad1-/- Smad5-/- KO mESC lines showed relatively fewer cells expressing 
mesendodermal markers and a dispersed pattern of NANOG-positive-cells, only line 1.35 
showed a different result. This suggests that Smad1 and Smad5 are not crucial factors for the 
formation of ME since there was mesoderm and endoderm formation in 2 out of 3 cell lines. 
Moreover, because the Smad1fl/fl Smad5fl/fl WT mESCs failed to upregulate STELLA during ME-
differentiation, we could use the derived Smad1-/- Smad5-/- KO mESC to study the impact of 
deleting Smad1 and Smad5 in the formation of PGCLCs. If the 129 genetic background proves to 
be a more suitable background to study induction of PGCs, we suggest the deletion of Smad5 
and Smad1 in 129 background. 
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In addition, it would be interesting to further investigate the presence of hematopoietic 
markers, like lmo297 and scl to help assess the ME-inducing medium differentiation induction 




IV. Final Remarks 
 
Further assays would be required to clearly understand if we were able to generate PGCLCs 
in genetic backgrounds other than 129 genetic background. FACS analysis would allow to have 
quantitative insight about differentiation efficiency, also including several timepoints would 
allow comparing the heterochrony between the in vitro generated cells and PGC cells in vivo. 
Nevertheless, we can conclude that the ME-differentiation protocol is a promising protocol to 
be further optimised in the induction of PGCLCs: it takes 6 days as the Hayashi-protocol, both 
step1 and step 2 occur in monolayer in contrast to the Hayashi-protocol with the formation of 
EBs in step 2, it does not need the exogenous addition of expensive growth factors and the 
number or PGCLCs formed in culture is relatively high. 
Unfortunately during the traineeship we were unable to derive a transgenic mESC line 
containing Blimp1:rfp. This would have allowed us to easily follow the induction of PGCLCs in 
vivo and perform FACS sorting and further molecular analysis. In the absence of the transgene, 
we gave the preference to study the double Smad1/5 KO mESC model. Here, because of the 
differences in genetic background we observed variation in the specification of PGCLCs, as the 
cells seem to upregulate the PGC-marker Stella. This caused difficulties proceeding with the 
analysis of Smad1/5 in PGC induction. 
Development is a highly complex process dependent on time and space gene expression 
and regulation.  Moreover, a single gene can have different functions in different contexts and 
numerous consequences in various biological processes98. The delicate balance between 
quantities and the heterochrony of these molecules is what allows an organism to successfully 
mature. Thus, it is essential to completely understand all the steps and sequences that occur in 




V. Supplemental Information  
Supplemental Figure 1. β-catenin in the transgenic cell lines. As a result of the activation of 
WNT signaling by CHIR, we expect to see staining in the nucleus of the cells. The staining 
however shows no signs of translocation of β-catenin into the nucleus. It might be that either a 
non-canonical is being activated instead or that this translocation happened in other time points 
after the start of induction. 
  











   







   
   
   
   






Supplemental Table 1. QPCR CT values of E14 differentiation. 
E14 N2B27 ME MEF 2i E14 N2B27 ME MEF 2i 
GAPDH 
19.31 18.51 19.43 18.89 
GAPDH 
21.44 25.70 28.35 26.99 
19.29 18.51 19.29 18.74 27.46 25.36 29.79 27.87 
19.40 18.45 19.37 18.75 28.02 25.77 28.06 26.42 
ACTB 
18.37 18.50 18.38 19.29 
Nanog 
23.03 17.84 21.98 17.53 
18.44 18.25 18.59 19.18 22.75 17.82 22.04 17.35 
18.50 18.13 18.52 19.79 22.94 17.94 21.76 17.22 
Oct4 
26.71 23.20 24.52 21.42 
     26.81 23.04 24.79 21.63 
     26.46 23.26 24.65 21.75 
     
Blimp1 
33.87 29.84 32.23 28.80 
     34.00 29.66 32.32 28.70 
     33.19 29.46 32.32 29.02 
     
Stella 
28.43 22.89 26.61 26.75 
     28.44 22.97 26.55 26.64 
     28.34 23.37 26.53 26.93 




Supplemental Table 2. QPCR ct values of Smad1fl/flSmad5fl/fl WT and KO 1.11 after 6 days 
of differentiation. 
 
WT N2B27 CHIR MEF 2i 
GAPDH 
17.62 17.34 16.19 15.29 
17.69 17.10 16.19 15.17 
17.70 17.33 16.23 15.33 
ACTB 
15.78 15.57 14.12 16.02 
15.87 15.70 14.07 15.87 
15.80 15.70 14.21 15.83 
Oct4 
27.41 23.62 22.73 19.05 
27.43 24.03 22.96 19.22 
27.29 23.97 22.67 19.12 
Blimp1 
27.54 27.68 29.34 28.27 
27.47 27.50 29.34 28.22 
27.43 27.79 29.40 28.51 
Stella 
29.68 25.31 26.35 19.07 
30.12 25.40 26.57 19.17 
30.08 25.47 26.47 19.18 
Nanog 
29.75 25.73 23.86 18.28 
29.29 25.67 24.11 18.02 
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